Trial Profile
A Randomized Double-Blind Control Trial of Intra-Articular Hyaluronic Acid:Botulinum Toxin Type a Versus Placebo for Mild to Moderate Knee Osteoarthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jun 2013
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Hyaluronic acid (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 23 Jun 2013 New trial record
- 15 Jun 2013 Results presented at the 14th Annual Congress of the European League Against Rheumatism.